Compliance Of Medication After Discharge From the Hospital in the Elderly (COMADE)

This study has been completed.
Sponsor:
Information provided by:
William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT01017432
First received: November 18, 2009
Last updated: April 2, 2011
Last verified: April 2011
  Purpose

Many elderly patients have multiple medications and variable dosing regimens and the ability for hospitals to properly reconcile medications between what is given on paper to the patient and what the patients take at home depends on the patient's ability to get the medications. Some patients may delay in getting their medications from the pharmacy after being discharged. For some it may be a lack of transportation, others may feel too ill to travel and may not have family members who will be able to pick up the medications.

It is for these reasons the authors of this study want to inventory the medications that an elderly patient is being discharged on during a home visit and check on the actual prescriptions that a patient has at their house the following 1-2 days after discharge.


Condition
Compliance of Medications
Factors That May Affect Compliance

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Compliance Of Medication After Discharge From the Hospital in the Elderly

Further study details as provided by William Beaumont Hospitals:

Primary Outcome Measures:
  • To observe compliance of medications from a discharge medication list to the meds at home after discharge from the hospital. [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To observe if there are secondary factors that affect compliance (i.e. age of the patients, number of medications or herbal medications) [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: December 2008
Study Completion Date: January 2011
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Detailed Description:

The goal is to evaluate the effectiveness of discharge instruction in the elderly by assessing medication compliance post-discharge. Patients are identified on the units and from a Beaumont Troy discharge planning master list. Prior to discharge the patients are consented and informed they will be contacted to schedule a home visit. During the home visit, the medications the patient is currently taking are recorded. Discharge medications are recorded from the medical record following the home visit. The Investigator performing the visit is blinded to the discharge medications as the intent of the visit is only to collect data and not to ensure compliance or make clinical judgment regarding the appropriateness of the medication regimen. Anyone 65 or older can be included, who are discharged with medications and can consent. Those excluded are patients who do not live in close proximity and those discharged to extended or long-term care facilities.

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

All patients over the age of 65 who are discharged home from the hospital who meet the eligibilty criteria.

Criteria

Inclusion Criteria:

  1. Elderly patients (age 65 or older)
  2. Able to make own decisions (Patient has autonomy) and therefore able to make informed decisions
  3. Patients with medications upon discharge from the hospital

Exclusion Criteria:

  1. Patients that have the inability to give informed consent secondary to: cognitive disabilities, inability to speak or write or refusal to participate in study.
  2. Patients that are younger than the age of 65.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01017432

Locations
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
William Beaumont Hospital
Troy, Michigan, United States, 48314
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: Jobin M Varughese, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Jobin Varughese, M.D., William Beaumont Hospital
ClinicalTrials.gov Identifier: NCT01017432     History of Changes
Other Study ID Numbers: HIC 2008-252
Study First Received: November 18, 2009
Last Updated: April 2, 2011
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on July 22, 2014